By 2015 JDRF had twenty-eight industry partners listed on its Web site. It had given Medtronic $17 million to develop a glucose sensor, partnered with Tandem Diabetes Care to make a new dual chamber pump, and invested $4.3 million in BD, a New Jersey–based medical device manufacturer, to fund projects like creating smaller needles that reduced pain. In late 2013 JDRF announced that it was “going the equity route,” joining with PureTech Ventures, a for-profit venture capital firm, to create a fund to fuel new diabetes start-ups.
